Lineage Cell Therapeutics Statistics

Total Valuation

LCTX has a market cap or net worth of $416.80 million. The enterprise value is $378.94 million.

Market Cap	416.80M
Enterprise Value	378.94M

Important Dates

The last earnings date was Thursday, November 6, 2025, after market close.

Earnings Date	Nov 6, 2025
Ex-Dividend Date	n/a

Share Statistics

LCTX has 242.33 million shares outstanding. The number of shares has increased by 25.54% in one year.

Current Share Class	242.33M
Shares Outstanding	242.33M
Shares Change (YoY)	+25.54%
Shares Change (QoQ)	+0.22%
Owned by Insiders (%)	5.12%
Owned by Institutions (%)	19.11%
Float	180.36M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	36.71
Forward PS	31.42
PB Ratio	17.97
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	35.03
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 4.50, with a Debt / Equity ratio of 0.13.

Current Ratio	4.50
Quick Ratio	4.33
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -157.75% and return on invested capital (ROIC) is -27.95%.

Return on Equity (ROE)	-157.75%
Return on Assets (ROA)	-13.65%
Return on Invested Capital (ROIC)	-27.95%
Return on Capital Employed (ROCE)	-25.34%
Revenue Per Employee	$140,468
Profits Per Employee	-$878,662
Employee Count	77
Asset Turnover	0.12
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +229.44% in the last 52 weeks. The beta is 1.78, so LCTX's price volatility has been higher than the market average.

Beta (5Y)	1.78
52-Week Price Change	+229.44%
50-Day Moving Average	1.74
200-Day Moving Average	1.04
Relative Strength Index (RSI)	49.51
Average Volume (20 Days)	2,179,563

Short Selling Information

The latest short interest is 22.58 million, so 9.32% of the outstanding shares have been sold short.

Short Interest	22.58M
Short Previous Month	31.77M
Short % of Shares Out	9.32%
Short % of Float	12.52%
Short Ratio (days to cover)	9.41

Income Statement

In the last 12 months, LCTX had revenue of $10.82 million and -$67.66 million in losses. Loss per share was -$0.29.

Revenue	10.82M
Gross Profit	-1.95M
Operating Income	-20.34M
Pretax Income	-67.51M
Net Income	-67.66M
EBITDA	-19.68M
EBIT	-20.34M
Loss Per Share	-$0.29

Full Income Statement

Balance Sheet

The company has $40.49 million in cash and $2.62 million in debt, giving a net cash position of $37.87 million or $0.16 per share.

Cash & Cash Equivalents	40.49M
Total Debt	2.62M
Net Cash	37.87M
Net Cash Per Share	$0.16
Equity (Book Value)	20.80M
Book Value Per Share	0.10
Working Capital	32.88M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$20.39 million and capital expenditures -$488,000, giving a free cash flow of -$20.88 million.

Operating Cash Flow	-20.39M
Capital Expenditures	-488,000
Free Cash Flow	-20.88M
FCF Per Share	-$0.09

Full Cash Flow Statement

Margins

Gross Margin	-17.98%
Operating Margin	-188.06%
Pretax Margin	-624.16%
Profit Margin	n/a
EBITDA Margin	-181.92%
EBIT Margin	-188.06%
FCF Margin	n/a

Dividends & Yields

LCTX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-25.54%
Shareholder Yield	-25.54%
Earnings Yield	-16.23%
FCF Yield	-5.01%

Dividend Details

Analyst Forecast

The average price target for LCTX is $4.25, which is 147.09% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$4.25
Price Target Difference	147.09%
Analyst Consensus	Strong Buy
Analyst Count	4
Revenue Growth Forecast (5Y)	60.35%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

The last stock split was on October 31, 1997. It was a forward split with a ratio of 3:1.

Last Split Date	Oct 31, 1997
Split Type	Forward
Split Ratio	3:1

Scores

LCTX has an Altman Z-Score of -6 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-6
Piotroski F-Score	3